The convertable debenture is my mental back stop as well, along with all of the "good" going on.

MY QUESTION for the Board:

Is there ANY way Hepa and Ken Dart can "snake" their money out without me getting mine for my common shares?

If not ... then I am betting not only on 20 yrs of research, BoM data, established Safety Profile, and BTD/FDA positioning ... but ALSO Hepa and Ken Dart.

I do not foresee this, however, for S's & G's ... In an abysmal "apocalyptic" world and scenario for RVX, Don has a "dream" and arrogantly holds out for $10b and no deal, out of money, belly up on the horizon ... I strongly believe Hepa/Dart would throw the $12m at Ori and with their potentially controlling interest (with a few more share blocks) force the sale of RVX for an amount to minimally get THEIR money back.

I believe they each bought a large number of shares for around $2.60, and is there anyone that believes RVX would not be sold and off the market to a BP at that price, which includes the IP and a large tax loss carry forward? ... a sale of around $600-700m, and gettting the tax loss to offset?! Plus apabetalone, and whatever future pipedream that product and IP can "someday" deliver in epigenetics? ... if that were to be the eventual "worst" case with a Bk looming?

So, if ANY of the above is true, and not fatally flawed logic (and it might be!!!) ... I feel very confident about getting at LEAST $2.60 back for this stock, because I think Hepa/Dart will make SURE that happens, at minimum, to at the very least get their investment back. At a VERY VERY sellable price, all things considered.

For those reasons, I have also been LOADING up the buggy with RVX under $.60 pps. Even at $2.60, that is a handsome return in the relative short term (apologies for any insensitivities to the 15-20 year club).

"IF" Hepa and Dart can't snake their cash out of their shares without me getting mine, then I feel good about at least getting my money back plus some ... even if not the big enchilada.

It would be beyond ridiculous that this company couldn't be sold for $2.60 pps and around $6-700m given the tax loss credit. Not my dream deal, but my safety deal.

I am betting on data data data, safety, BTD/FDA, and ... plus GREED ... of Hepa, Dart, and ultimately a BP, to work together for a deal in the worst case, ... if Don cannot git'r'dun ... and a GREAT deal in the better cases.

Go ahead now ... burst my bubble :)